Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy

Q Zhao, H Liu, L Tang, F Wang, G Tolufashe, J Chang… - Antiviral research, 2024‏ - Elsevier
Hepatitis B virus (HBV) chronically infects 296 million people worldwide and causes more
than 820,000 deaths annually due to cirrhosis and hepatocellular carcinoma. Current …

Restriction factors: from intrinsic viral restriction to sha** cellular immunity against HIV-1

M Colomer-Lluch, A Ruiz, A Moris… - Frontiers in …, 2018‏ - frontiersin.org
Antiviral restriction factors are host cellular proteins that constitute a first line of defense
blocking viral replication and propagation. In addition to interfering at critical steps of the …

Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins

E Braun, D Hotter, L Koepke, F Zech, R Groß… - Cell reports, 2019‏ - cell.com
Summary Guanylate-binding protein (GBP) 5 is an interferon (IFN)-inducible cellular factor
reducing HIV-1 infectivity by an incompletely understood mechanism. Here, we show that …

Interferon resistance of emerging SARS-CoV-2 variants

K Guo, BS Barrett, JH Morrison, KL Mickens… - Proceedings of the …, 2022‏ - pnas.org
The emergence of SARS-CoV-2 variants with enhanced transmissibility, pathogenesis, and
resistance to vaccines presents urgent challenges for curbing the COVID-19 pandemic …

Interferon‐based treatment of chronic hepatitis D

L Sandmann, H Wedemeyer - Liver International, 2023‏ - Wiley Online Library
Abstract Treatment of hepatitis D virus (HDV) infection has been based on the administration
of interferon‐alfa for more than three decades. First studies to treat HDV‐infected patients …

Type I interferon signaling, regulation and gene stimulation in chronic virus infection

S Lukhele, GM Boukhaled, DG Brooks - Seminars in immunology, 2019‏ - Elsevier
Abstract Type I Interferons (IFN-I) mediate numerous immune interactions during viral
infections, from the establishment of an antiviral state to invoking and regulating innate and …

[HTML][HTML] Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs

L Cheng, J Ma, J Li, D Li, G Li, F Li, Q Zhang… - The Journal of clinical …, 2017‏ - jci.org
Chronic immune activation, immunosuppression, and T cell exhaustion are hallmarks of HIV
infection, yet the mechanisms driving these processes are unclear. Chronic activation can …

Interferon lambda genetics and biology in regulation of viral control

EA Hemann, M Gale Jr, R Savan - Frontiers in immunology, 2017‏ - frontiersin.org
Type III interferons, also known as interferon lambdas (IFNλs), are the most recent addition
to the IFN family following their discovery in 2003. Initially, IFNλ was demonstrated to induce …

Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness

SS Iyer, F Bibollet-Ruche, S Sherrill-Mix… - Proceedings of the …, 2017‏ - pnas.org
Sexual transmission of HIV-1 is an inefficient process, with only one or few variants of the
donor quasispecies establishing the new infection. A critical, and as yet unresolved …

[HTML][HTML] Herpes simplex virus type 1 interactions with the interferon system

K Danastas, M Miranda-Saksena… - International journal of …, 2020‏ - mdpi.com
The interferon (IFN) system is one of the first lines of defense activated against invading viral
pathogens. Upon secretion, IFNs activate a signaling cascade resulting in the production of …